Sandbox:farnaz: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) |
Usama Talib (talk | contribs) |
||
Line 39: | Line 39: | ||
| | | | ||
|} | |} | ||
==References== |
Revision as of 15:46, 26 January 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farnaz Khalighinejad, MD [2]
Overview
MS is known as multiple sclerosis.
Multiple Sclerosis
ajksfshvanivlk
Type 1:
asdad
Type 2:
The primary therapy for MS may include:[1]
- B-interferon
- Teleflunomide
Cause | Symptom | Diagnosis | Treatment |
---|---|---|---|
1 | |||
2 | |||
3 |
References
- ↑ Kamm CP, Uitdehaag BM, Polman CH (2014). "Multiple sclerosis: current knowledge and future outlook". Eur Neurol. 72 (3–4): 132–41. doi:10.1159/000360528. PMID 25095894.